Roseburia intestinalis Modulates PYY Expression in a New a Multicellular Model including Enteroendocrine Cells
-
Published:2022-11-15
Issue:11
Volume:10
Page:2263
-
ISSN:2076-2607
-
Container-title:Microorganisms
-
language:en
-
Short-container-title:Microorganisms
Author:
Gautier ThomasORCID, Fahet Nelly, Tamanai-Shacoori Zohreh, Oliviero NolwennORCID, Blot Marielle, Sauvager AurélieORCID, Burel Agnes, Gall Sandrine David-Le, Tomasi SophieORCID, Blat Sophie, Bousarghin LatifaORCID
Abstract
The gut microbiota contributes to human health and disease; however, the mechanisms by which commensal bacteria interact with the host are still unclear. To date, a number of in vitro systems have been designed to investigate the host–microbe interactions. In most of the intestinal models, the enteroendocrine cells, considered as a potential link between gut bacteria and several human diseases, were missing. In the present study, we have generated a new model by adding enteroendocrine cells (ECC) of L-type (NCI-H716) to the one that we have previously described including enterocytes, mucus, and M cells. After 21 days of culture with the other cells, enteroendocrine-differentiated NCI-H716 cells showed neuropods at their basolateral side and expressed their specific genes encoding proglucagon (GCG) and chromogranin A (CHGA). We showed that this model could be stimulated by commensal bacteria playing a key role in health, Roseburia intestinalis and Bacteroides fragilis, but also by a pathogenic strain such as Salmonella Heidelberg. Moreover, using cell-free supernatants of B. fragilis and R. intestinalis, we have shown that R. intestinalis supernatant induced a significant increase in IL-8 and PYY but not in GCG gene expression, while B. fragilis had no impact. Our data indicated that R. intestinalis produced short chain fatty acids (SCFAs) such as butyrate whereas B. fragilis produced more propionate. However, these SCFAs were probably not the only metabolites implicated in PYY expression since butyrate alone had no effect. In conclusion, our new quadricellular model of gut epithelium could be an effective tool to highlight potential beneficial effects of bacteria or their metabolites, in order to develop new classes of probiotics.
Subject
Virology,Microbiology (medical),Microbiology
Reference62 articles.
1. Gut Microbiome and Health: Mechanistic Insights;Gut,2022 2. Role of the Gastrointestinal Tract Microbiome in the Pathophysiology of Diabetes Mellitus;J. Diabetes Res.,2017 3. Inflammation as a Link between Obesity, Metabolic Syndrome and Type 2 Diabetes;Diabetes Res. Clin. Pract.,2014 4. Kashtanova, D.A., Tkacheva, O.N., Doudinskaya, E.N., Strazhesko, I.D., Kotovskaya, Y.V., Popenko, A.S., Tyakht, A.V., and Alexeev, D.G. (2018). Gut Microbiota in Patients with Different Metabolic Statuses: Moscow Study. Microorganisms, 6. 5. Takagi, T., Naito, Y., Kashiwagi, S., Uchiyama, K., Mizushima, K., Kamada, K., Ishikawa, T., Inoue, R., Okuda, K., and Tsujimoto, Y. (2020). Changes in the Gut Microbiota Are Associated with Hypertension, Hyperlipidemia, and Type 2 Diabetes Mellitus in Japanese Subjects. Nutrients, 12.
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|